Masahiko Ando

15.2k citations

463 papers · 9.5k indexed · h-index 48

Impact in

Pulmonary and Respiratory Medicine top 0.2%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Gastric Cancer Management and Outcomes
- Tracheal and airway disorders
Oncology top 0.5%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies

Papers in

Pulmonary and Respiratory Medicine 188
- Lung Cancer Treatments and Mutations 77
- Lung Cancer Diagnosis and Treatment 59
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 26
- Gastric Cancer Management and Outcomes 20
Oncology 122
- Lung Cancer Research Studies 48
- Colorectal Cancer Treatments and Studies 30
- Pancreatic and Hepatic Oncology Research 19

Co-authors: Hideo Saka Yoshinori Hasegawa Yoshihito Kogure Chiyoe Kitagawa Koji Takeda Masahiro Fukuoka Takashi Kawamura Nobuyuki Yamamoto
Journals: Journal of Clinical Oncology (37 papers)PLoS ONE (14 papers)Journal of Epidemiology (14 papers)Respirology (11 papers)Japanese Journal of Clinical Oncology (10 papers)
Partner nations: Japan United States China

In The Last Decade

Masahiko Ando

442 papers receiving 9.3k citations

Peers

Countries citing papers authored by Masahiko Ando

Since Specialization

Citations

This map shows the geographic impact of Masahiko Ando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiko Ando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiko Ando more than expected).

Fields of papers citing papers by Masahiko Ando

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahiko Ando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiko Ando. The network helps show where Masahiko Ando may publish in the future.

Co-authors

The 25 scholars most cited alongside Masahiko Ando, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Masahiko Ando Line = papers co-authored together Masahiko Ando links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cancer Therapy-Related Cardiac Dysfunction in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Treated With Trastuzumab and Pertuzumab Circulation Reports ·Е Н Игнатова, Ryota Morimoto, S. Kazama, Hiroaki Hiraiwa, Toru Kondo, Yuko Takano, Dipankar Chatterjee -, Tomoya Shimokata, Yachiyo Kuwatsuka, Yoshiyuki Bando, Masahiko Ando, Н. А. Забелин, Kayleigh Newman	2025	1
2	An Upward Multi‐Pulse TGF Involved With Two Thunderstorm Cells Journal of Geophysical Research Atmospheres ·Kazuhiro Nakazawa, M Oguchi, Ting Wu, Yuuki Wada, В А Аксенов, Daohong Wang, Yoshiyuki Tsuji, �mer Er�etin, Masahiko Ando, Teruaki Enoto, Khageshwar Pradhan, J. Kataoka, T. Kanda, С. А. Файзуллина, Lara Deidersen, Taro Shinoda, Patricia-Ann Lee, Winda Harsanti	2025	0
3	Assessing the Real-World, Long-Term Impact of Lemborexant on Sleep Quality in a Home-Based Clinical Study Nature and Science of Sleep ·Seiko Miyata, Kunihiro Iwamoto, Adekunle Isiaka Obasa, Akihiro Fujimoto, sundulpoker, Daisuke Mori, Manabu Amano, 昭子荒川, Kazuki Nishida, Masahiko Ando, Toshiaki Taoka, Shinji Naganawa, Norio Ozaki	2024	6
4	Mechanisms of resistance and correlation between pre-treatment co-alterations and p-prognosis to osimertinib in chemo-naïve advanced non-small cell lung cancer Lung Cancer ·Akihiro Tamiya, G.D. Anandamurthy, Daijiro Harada, Shun‐ichi Isa, Yoshihiko Taniguchi, Hye-Sun Ko, 正弘大森, Tsutomu Shinohara, 兰雄现, Katsumi Nakatomi, Masahide Oki, Masahide Mori, S. Garnov, Koji Yamazaki, Atsuhisa Tamura, Masahiko Ando, Yasuhiro Koh	2024	4
5	Utility of adding oesophageal to endobronchial endosonography when staging lung cancer: a randomised trial ERJ Open Research ·Masahide Oki, Dewi Fatimah, Yukio Seki, Proskurina Va, Shigeto Oota, Weixian Xu, P Wyszomirski, Chiyoe Kitagawa, Masahiko Ando	2024	1
6	Dual decline in subjective gait speed and domain-specific cognition is associated with higher risk of incident dementia in older Japanese adults: A 15-year age-specific cohort study Archives of Gerontology and Geriatrics ·N.V. Safina, Farzaneh Bayat, Takashi Kimura, Shigekazu Ukawa, Hideki Ohira, Satoe Okabayashi, Kenji Wakai, Masahiko Ando, Akiko Tamakoshi	2023	3
7	Carboplatin and irinotecan (CI) vs. carboplatin and etoposide (CE) for the treatment of extended-stage small-cell lung cancer in an elderly population: A phase II/III randomized control trial Lung Cancer ·Tsuneo Shimokawa, Hiroaki Okamoto, Ryunosuke Machida, P. Bordé, Yukio Hosomi, Yasuto Yoneshima, Hiroshi Tanaka, Kyoichi Okishio, F. Z. Igbua, Kōichi Goto, Hiroaki Akamatsu, Kaoru Kubota, Kazuhiko Nakagawa, Hidehito Horinouchi, Masahiko Ando, Tomoko Kataoka, Yuichiro Ohe	2023	4
8	Association between serum iron markers, iron supplementation and cardiovascular morbidity in pre-dialysis chronic kidney disease Nephrology Dialysis Transplantation ·Takeshi Hasegawa, Takahiro Imaizumi, Takayuki Hamano, Kenta Murotani, Naohiko Fujii, Hirotaka Komaba, Masahiko Ando, Shoichi Maruyama, Masaomi Nangaku, Kosaku Nitta, Hideki Hirakata, Yoshitaka Isaka, Takashi Wada, Masafumi Fukagawa	2023	8
9	Improved glycemic control after the use of flash glucose monitoring accompanied by improved treatment satisfaction in patients with non-insulin-treated type 2 diabetes: A post-hoc analysis of a randomized controlled trial Primary care diabetes ·J Skea, Takeshi Onoue, Muhammad Fakhruddin Abd Wahid, Eri Wada, Andrea Torres P., T Kinoshita, Liliana Vilas Boas, Yoshinori Yasuda, Shintaro Iwama, 正晴北村, Takashi Miyata, Mariko Sugiyama, Hiroshi Takagi, Daisuke Hagiwara, Hidetaka Suga, Ryoichi Banno, Yachiyo Kuwatsuka, Masahiko Ando, Motomitsu Goto, Hiroshi Arima	2023	1
10	Incidence rate of chronic pain after 1.5-2 years of thoracotomy between paravertebral block versus epidural block: a cohort study. PubMed ·F G Bivins, Takahiro Tamura, Shuichi Yokota, Sinus Hegen, Masahiko Ando, Yoko Kubo, Kimitoshi Nishiwaki	2022	1
11	Value of adding ultrathin bronchoscopy to thin bronchoscopy for peripheral pulmonary lesions: A multicentre prospective study Respirology ·Masahide Oki, Hideo Saka, Daisuke Himeji, Tatsuya Imabayashi, Yoichi Nishii, Masahiko Ando	2022	9
12	Association between serum magnesium levels and abdominal aorta calcification in patients with pre-dialysis chronic kidney disease stage 5 PLoS ONE ·Mayumi Ito, Makoto Yamaguchi, Takayuki Katsuno, Brahmankar Dm, Shiho Iwagaitsu, J Li, Hiroshi Kinashi, Shogo Banno, Masahiko Ando, Yoko Kubo, Takuji Ishimoto, Yasuhiko Ito	2021	8
13	A Multicenter, Randomized Phase III Study Comparing Platinum Combination Chemotherapy Plus Pembrolizumab With Platinum Combination Chemotherapy Plus Nivolumab and Ipilimumab for Treatment-Naive Advanced Non–Small Cell Lung Cancer Without Driver Gene Alterations: JCOG2007 (NIPPON Study) Clinical Lung Cancer ·Yoshimasa Shiraishi, Taiki Hakozaki, Shogo Nomura, Tomoko Kataoka, Kentaro Tanaka, Satoru Miura, Yuta Sekino, Masahiko Ando, Hidehito Horinouchi, Yuichiro Ohe, Isamu Okamoto	2021	18
14	Time-dependent discrepancies between physician-assessed and patient-reported oxaliplatin-induced peripheral neuropathy in patients with metastatic colorectal cancer who received mFOLFOX6 plus bevacizumab: a post hoc analysis (WJOG4407GSS2) Supportive Care in Cancer ·Yuji Miura, Masahiko Ando, Kentaro Yamazaki, Shuichi Hironaka, Narikazu Boku, Kei Muro, Ichinosuke Hyodo	2020	7
15	A placebo-controlled, double-blind, randomized study of recombinant thrombomodulin (ART-123) to prevent oxaliplatin-induced peripheral neuropathy Cancer Chemotherapy and Pharmacology ·Masahito Kotaka, Yoji Saito, Takeshi Kato, Hironaga Satake, Akitaka Makiyama, Yasushi Tsuji, Katsunori Shinozaki, Toshiyoshi Fujiwara, Tsunekazu Mizushima, Yasushi Harihara, Naoki Nagata, Naoto Kurihara, Masahiko Ando, Ali Fardi Ilkhchi, Takumi Sakai, Nuo Ding, 土屋新男, Hendrielly Henrique Fontoura Veras, Ichinosuke Hyodo	2020	16
16	Correction to: A placebo‑controlled, double‑blind, randomized study of recombinant thrombomodulin (ART‑123) to prevent oxaliplatin‑induced peripheral neuropathy Cancer Chemotherapy and Pharmacology ·Masahito Kotaka, Yoji Saito, Takeshi Kato, Hironaga Satake, Akitaka Makiyama, Yasushi Tsuji, Katsunori Shinozaki, Toshiyoshi Fujiwara, Tsunekazu Mizushima, Yasushi Harihara, Naoki Nagata, Naoto Kurihara, Masahiko Ando, Ali Fardi Ilkhchi, Takumi Sakai, Nuo Ding, 土屋新男, Hendrielly Henrique Fontoura Veras, Ichinosuke Hyodo	2020	2
17	Treatment patterns and steroid dose for adult minimal change disease relapses: A retrospective cohort study PLoS ONE ·Q. LIU, Masahiko Ando, Makoto Yamaguchi, Takayuki Katsuno, Sawako Kato, Yoshinari Yasuda, Naotake Tsuboi, Shoichi Maruyama	2018	7
18	Optical Implementation of Reservoir Computing for Fast Integrative Analysis in Sensor Array Processing H Petersen, M. Tai, Masahiko Ando	2017	2
19	Phase II Study of Carboplatin and Pemetrexed in Advanced EGFR-wild-type Non-squamous Non-small Cell Lung Cancer: The Central Japan Lung Study Group Trial 0906. PubMed ·Tomoki Kimura, Hiroyuki Taniguchi, Naohiro Watanabe, Hideo Saka, Yoshihito Kogure, Xianwen Yue, Tomohiko Ogasawara, Eiji Kojima, Yoshinori Hasegawa, Masashi Yamamoto, Ryujiro Suzuki, Masahiko Ando, Masashi Kondo, Hiroshi Saito	2016	4
20	Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non–Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR Clinical Cancer Research ·Masaru Watanabe, Tomoya Kawaguchi, Shun‐ichi Isa, Masahiko Ando, Akihiro Tamiya, Akihito Kubo, Hideo Saka, Sadanori Takeo, Hirofumi Adachi, Tsutomu Tagawa, Seiichi Kakegawa, Motohiro Yamashita, Kazuhiko Kataoka, Yukito Ichinose, Yukiyasu Takeuchi, Kazuhiro Sakamoto, Akihide Matsumura, Yasuhiro Koh	2015	182

About Masahiko Ando

Masahiko Ando is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Nephrology, Geriatrics and Gerontology and Surgery, having authored 463 papers that have together received 9.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (77 papers), Lung Cancer Diagnosis and Treatment (59 papers), Lung Cancer Research Studies (48 papers), Colorectal Cancer Treatments and Studies (30 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (26 papers), Gastric Cancer Management and Outcomes (20 papers), Pancreatic and Hepatic Oncology Research (19 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (17 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.6k citations), Oncology (2.7k citations), Nephrology (361 citations), Geriatrics and Gerontology (170 citations) and Surgery (1.7k citations). Masahiko Ando has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Hideo Saka, Yoshinori Hasegawa, Yoshihito Kogure, Chiyoe Kitagawa, Koji Takeda, Masahiro Fukuoka, Takashi Kawamura, Nobuyuki Yamamoto, Takashi Seto and Kazuhiko Nakagawa. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE, Journal of Epidemiology, Respirology and Japanese Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact